Canadian guideline for safe and effective use of opioids for chronic noncancer pain - Clinical summary for family physicians. Part 1: General population;Lignes directrices canadiennes sur l'utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse - Résumé clinique pour les médecins de famille. Partie 1: Population en général

Canadian Family Physician

Volumn 57, Issue 11, 2011, Pages 1257-1266

  Kahan, Meldon ^a,b,c   Mailis Gagnon, Angela ^d,e,f   Wilson, Lynn ^a,c   Srivastava, Anita ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b Addiction Medicine Service   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f ACTION Ontario Centre for the Study of Pain   (Canada)

^g CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; CODEINE; DIAZEPAM; FENTANYL; HYDROMORPHONE; LORAZEPAM; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; PETHIDINE; TRAMADOL;

AMBULATORY CARE; ANALGESIA; BEHAVIOR THERAPY; CHRONIC PAIN; CONSULTATION; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED RELEASE FORMULATION; DIABETIC NEUROPATHY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; DYSPHORIA; EMERGENCY CARE; FIBROMYALGIA; FRACTURE; GENERAL PRACTITIONER; HUMAN; HYPERALGESIA; LOW BACK PAIN; LOW DRUG DOSE; MENTAL DISEASE; NECK PAIN; NEUROPATHIC PAIN; NOCICEPTION; OPIATE ADDICTION; OPTIMAL DRUG DOSE; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; PATIENT TRANSPORT; PERIPHERAL NEUROPATHY; PHANTOM PAIN; PHYSICAL EXAMINATION; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; RADICULOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SCREENING; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SLEEP APNEA SYNDROME; SPINAL CORD INJURY; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; BENZODIAZEPINES; CANADA; CHRONIC PAIN; CODEINE; HUMANS; HYDROMORPHONE; MASS SCREENING; OPIOID-RELATED DISORDERS; OXYCODONE; PATIENT EDUCATION AS TOPIC; SLEEP APNEA SYNDROMES; TRAMADOL;

EID: 81855218048     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181(12):891-6. Cyberpub. du 7 décembre 2009.
2. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007;297(3):249-51. (Pubitemid 46143290)
3. Furlan AD, Reardon R, Weppler C. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 2010;182(9):923-30. Cyberpub. du 3 mai 2010.
4. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174(11):1589-94. (Pubitemid 43829515)
5. National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Hamilton, ON: McMaster University; 2010. Acessible à: http://nationalpaincentre.mcmaster.ca/ opioid/cgop- a00-executive-summary.html. Accédé le 20 septembre 2011.
6. Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain. Clinical summary for family physicians. Part 2: special populations. Can Fam Physician 2011;57:1269-76 (ang), e419-28 (fr).
7. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000;6(5):250-7.
8. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003;114(7):537-45. (Pubitemid 36577256)
9. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et collab. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67(4):536-41. Cyberpub. du 20 juillet 2007.
10. Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007;(3):CD004959.
11. Chou R. Pharmacological management of low back pain. Drugs 2010;70(4):387-402.
12. Wang H, Weinsheimer N, Akbar M, Schiltenwolf M. [Altered pain thresholds during and after opioid withdrawal in patients with chronic low back pain.] Article en allemand. Schmerz 2010;24(3):257-61.
13. Nuesch E, Rutjes AW, Husni E, Welch V, Juni P. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;(4):CD003115.
14. Dagenais S, Tricco AC, Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J 2010;10(6):514-29.
15. Strand LI, Ljunggren AE, Bogen B, Ask T, Johnsen TB. The Short-Form McGill Pain Questionnaire as an outcome measure: test-retest reliability and responsiveness to change. Eur J Pain 2008;12(7):917-25.
16. e éd. St Louis, MO: Mosby Inc; 1999.
17. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349(20):1943-53. (Pubitemid 37409712)
18. Daniell HW. DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J Pain 2006;7(12):901-7. (Pubitemid 44854733)
19. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006;7(1):43-8. (Pubitemid 43097262)
20. Zgierska A, Brown RT, Zuelsdorff M, Brown D, Zhang Z, Fleming MF. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: a cross-sectional study. J Opioid Manag 2007;3(6):317-27. (Pubitemid 351166543)
21. Mogri M, Khan MI, Grant BJ, Mador MJ. Central sleep apnea induced by acute ingestion of opioids. Chest 2008;133(6):1484-8. (Pubitemid 351893009)
22. Farney RJ, Walker JM, Cloward TV, Rhondeau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003;123(2):632-9. (Pubitemid 36269457)
23. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152(11):712-20.
24. KahanM, Srivastava A, Wilson L, Mailis-Gagnon A, Midmer D. Opioids for managing chronic non-malignant pain: safe and effective prescribing. Can Fam Physician 2006;52(9):1091-6. (Pubitemid 44553331)
25. Mirakbari SM, Innes GD, Christenson J, Tilley J, Wong H. Do co-intoxicants increase adverse event rates in the first 24 hours in patients resuscitated from acute opioid overdose? J Toxicol Clin Toxicol 2003;41(7):947-53. (Pubitemid 38018485)
26. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, et collab. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol 2003;27(2):57-67.
27. Repchinsky C, rédacteur en chef. Compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals. Ottawa, ON: Association des pharmaciens du Canada; 2008.
28. Schreiber S, Peles E, Adelson M. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 2008;92(1-3):79-85. Cyberpub. du 13 aoÛt 2007.
29. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169(10):1015-20. (Pubitemid 37449350)
30. Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L. Benzodiazepine discontinuation among adults with GAD: a randomized trial of cognitive-behavioral therapy. J Consult Clin Psychol 2006;74(5):908-19. (Pubitemid 44547485)
31. Vicens C, Fiol F, Llobera J, Campoamor F, Mateu C, Alegret S, et collab. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. Br J Gen Pract 2006;56(533):958-63.
32. Moroz G, Rosenbaum JF. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. J Clin Psychiatry 1999;60(9):604-12. (Pubitemid 29451557)
33. Cook JM, Biyanova T, Thompson R, Coyne JC. Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines. Gen Hosp Psychiatry 2007;29(5):396-401. (Pubitemid 47410310)
34. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallieres A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004;161(2):332-42. (Pubitemid 38425457)
35. Dasgupta N, Kramer ED, Zalman MA, Carino S Jr, Smith MY, Haddox JD, et collab. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006;82(2):135-42. Cyberpub. du 19 octobre 2005.
36. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991;27(1):7-17.
37. Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, et collab. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994- 2004. Pharmacoepidemiol Drug Saf 2005;14(12):851-9.
38. Peterson GM, Randall CT, Paterson J. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration. Eur J Clin Pharmacol 1990;38(2):121-4. (Pubitemid 20097314)
39. Tyndale RF, Droll KP, Sellers EM. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 1997;7(5):375-9. (Pubitemid 27427547)
40. Romach MK, Otton SV, Somer G, Tyndale RF, Sellers EM. Cytochrome P450 2D6 and treatment of codeine dependence. J Clin Psychopharmacol 2000;20(1):43-5. (Pubitemid 30056352)
41. Howard LA, Sellers EM, Tyndale RF. The role of pharmacogenetically- variable cytochrome P450 enzymes in. Pharmacogenomics 2002;3(2):185-99. (Pubitemid 34223856)
42. Shields LB, Hunsaker JC 3rd, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci 2007;52(6):1389-95. (Pubitemid 350243438)
43. Sims SA, Snow LA, Porucznik CA. Surveillance of methadone-related adverse drug events using multiple public health data sources. J Biomed Inform 2007;40(4):382-9. Epub 2006 Nov 1.
44. Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 2004;24(6):776-83. (Pubitemid 38747863)
45. Zacny JP, Lichtor SA. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology (Berl) 2008;196(1):105-16. Cyberpub. du 27 septembre 2007.
46. Lamas X, Farré M, Moreno V, Camí J. Effects of morphine in post addict humans: a meta-analysis. Drug Alcohol Depend 1994;36(2):147-52. (Pubitemid 24297675)
47. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et collab. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152(2):85-92.
48. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94(2):149-58. (Pubitemid 33016608)
49. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22(2):672-87. (Pubitemid 32725810)
50. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 2003;26(5):1055-61. (Pubitemid 37324686)
51. Walker JM, Farney RJ, Rhondeau SM, Boyle KM, Valentine K, Cloward TV, et collab. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007;3(5):455-61. Erratum dans: J Clin Sleep Med 2007;3(6):table of contents.
52. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9(4):425-32. (Pubitemid 351722516)
53. Alattar MA, Scharf SM. Opioid-associated central sleep apnea: a case series. Sleep Breath 2009;13(2):201-6. Cyberpub. du 20 septembre 2008.
54. Cohen SP, Christo PJ, Wang S, Chen L, Stojanovic MP, Shields CH, et collab. The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus. Reg Anesth Pain Med 2008;33(3):199-206.
55. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med 2006;260(1):76-87. (Pubitemid 43894073)
56. Hass B, Lungershausen J, Hertel N, Poulsen Nautrup B, Kotowa W, Liedgens H. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. Eur J Health Econ 2009;10(3):309-21. Cyberpub. du 21 décembre 2008.
57. Gomes T, Juurlink D, Dhalla I, Mailis-Gagnon A, Paterson M, Mamdani M. Trends in opioid use and dosing among the socioeconomically disadvantaged. Open Med 2011;5(1):e13.
58. Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA, Hodgson JE. Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc 2004;79(6):759-68. (Pubitemid 38691827)
59. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM; Disability Risk Identification Study Cohort. Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine 2008;33(2):199-204.
60. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003;4(6):344-50. (Pubitemid 37013026)
61. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, et collab. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009;31(6):564-70. Cyberpub. du 27 aoÛt 2009.
62. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004;(3):CD004847.
63. Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag 2006;2(5):277-82.
64. Becker N, Sjøgren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000;84(2-3):203-11. (Pubitemid 30074222)
65. Miller NS, Swiney T, Barkin RL. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. Am J Ther 2006;13(5):436-44. (Pubitemid 44435017)
66. Ralphs JA, Williams AC, Richardson PH, Pither CE, Nicholas MK. Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods. Pain 1994;56(3):279-88. (Pubitemid 24087978)
67. Crisostomo RA, Schmidt JE, Hooten WM, Kerkvliet JL, Townsend CO, Bruce BK. Withdrawal of analgesic medication for chronic low-back pain patients: improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history. Am J Phys Med Rehabil 2008;87(7):527-36.
68. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007;8(1):8-16. (Pubitemid 46128762)
69. Peng P, Choiniere M, Dion D, Intrater H, Lefort S, Lynch M, et collab. Challenges in accessing multidisciplinary pain treatment facilities in Canada. Can J Anaesth 2007;54(12):977-84.